By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Idera Pharmaceuticals, Inc. 

167 Sidney Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-679-5500 Fax: 617-679-5592


Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. Our proprietary drug candidates are designed to modulate specific Toll-like Receptors, which are a family of immune system receptors that direct immune system responses. Our pioneering DNA and RNA chemistry expertise enables us to create drug candidates for internal development and generates opportunities for multiple collaborative alliances.

For more information, visit

Key Statistics

Ownership: Public

Web Site: Idera Pharmaceuticals, Inc.
Symbol: IDRA

Company News
Idera Pharmaceuticals, Inc. (IDRA) Announces Leadership Appointments 1/27/2015 7:43:39 AM
Idera Pharmaceuticals, Inc. (IDRA) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/9/2015 10:16:36 AM
Idera Pharmaceuticals, Inc. (IDRA) Provides Key Updates On Clinical Development Of IMO-8400 For Treatment Of Waldenstrom's Macroglobulinemia 12/30/2014 7:23:08 AM
Idera Pharmaceuticals, Inc. (IDRA) Announces Several Key Additions To Management Team 12/15/2014 8:10:25 AM
Idera Pharmaceuticals, Inc. (IDRA) Presents Data Supporting IMO-8400 As Novel Therapy For Genetically Defined Forms Of B-Cell Lymphoma At Annual American Society of Hematology Meeting 12/9/2014 10:59:22 AM
Idera Pharmaceuticals, Inc. (IDRA) Announces Appointment Of Robert A. Doody Jr. As Vice President Of Investor Relations And Corporate Communications 12/5/2014 9:55:17 AM
Idera Pharmaceuticals, Inc. (IDRA) Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models 12/3/2014 11:15:41 AM
Idera Pharmaceuticals, Inc. (IDRA) Names Vincent J. Milano CEO 12/2/2014 7:54:32 AM
Idera Pharmaceuticals, Inc. (IDRA) To Present At The Stifel 2014 Healthcare Conference 11/13/2014 10:39:22 AM
Idera Pharmaceuticals, Inc. (IDRA) And Parent Project Muscular Dystrophy Announce Collaboration To Advance New Treatment Approach For Duchenne Muscular Dystrophy 11/7/2014 10:41:28 AM